InBody인바디
041830 · KOSDAQ · ₩041830 · 인바디
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩72,798
vs the current price (₩46,550)
- Enterprise value
- ₩918B
- Equity value
- ₩981B
- WACC
- 7.3%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 56% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- To match today's price of ₩46,550, the model needs an operating margin of 13.9% every year (it uses 21.2%).
- Or revenue growth −12.8 points a year higher than assumed in each of the 5 years.
- Margins ranged from 15.7% to 26.0% over the last 5 years, so this is a cyclical business. The model uses the average; the price may be set by where the cycle is now. Try the margin fade option.
- Today's P/E is 13.5× against a typical 10.4× over the last 10 years.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩50,236
- +7.9%
- Base
- ₩72,798
- +56.4%
- Bull
- ₩110,108
- +136.5%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (21.2%).
Revenue growth
- 13.5%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (13.5% a year, annual reports), fading to 3% by year 5.
- 10.9%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (13.5% a year, annual reports), fading to 3% by year 5.
- 8.3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (13.5% a year, annual reports), fading to 3% by year 5.
- 5.6%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (13.5% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (13.5% a year, annual reports), fading to 3% by year 5.
Business
- 21.2%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 3%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 3.8%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 40%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.01%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-30.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 104 weeks of weekly returns against KOSPI (official index); raw beta 0.24, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.51%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩264B
- Net debt (borrowings and leases − cash and deposits)
- −₩58B
- + Stakes and investments
- ₩8.1B
- Associates, long-term financial assets and deposits (book value)
- − Minority interests
- ₩2.5B
- Shares
- 13,480,882
- Share price
- ₩46,550
- Market cap
- ₩628B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩170B | ₩204B | ₩234B | ₩300B | ₩332B | ₩360B | ₩380B | ₩391B |
| Growth | 6.5% | 20.0% | 14.4% | 13.5% | 10.9% | 8.3% | 5.6% | 3.0% |
| EBIT | ₩38B | ₩37B | ₩37B | ₩63B | ₩70B | ₩76B | ₩81B | ₩83B |
| EBIT margin | 22.5% | 18.0% | 15.7% | 21.2% | 21.2% | 21.2% | 21.2% | 21.2% |
| After-tax EBIT | ₩28B | ₩27B | ₩27B | ₩46B | ₩51B | ₩55B | ₩58B | ₩60B |
| + Depreciation | — | — | — | ₩9B | ₩10B | ₩11B | ₩11B | ₩12B |
| − Capital spending | ₩7.6B | ₩7.6B | ₩7.4B | ₩11B | ₩13B | ₩14B | ₩14B | ₩15B |
| − Working capital | ₩16B | ₩8B | ₩4.9B | ₩14B | ₩13B | ₩11B | ₩8.1B | ₩4.6B |
| Free cash flow | — | — | — | ₩29B | ₩35B | ₩41B | ₩47B | ₩52B |
| Discount factor | — | — | — | 0.932 | 0.868 | 0.809 | 0.754 | 0.703 |
| Present value | — | — | — | ₩27B | ₩31B | ₩33B | ₩36B | ₩37B |
Terminal value ₩1.1T, worth ₩754B today: 82% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩25,522 a share)Now 1.82× | ₩30,1011.18× | ₩38,2721.50× | ₩49,9631.96× |
| Price / earnings (last 12 months: ₩3,453 a share)Now 13.5× | ₩30,4408.82× | ₩36,05210.4× | ₩46,43213.4× |
| P/E on run-rate earnings (Q2 2026 × 4: ₩4,201 a share)Now 11.1× | ₩37,0398.82× | ₩43,86910.4× | ₩56,50013.4× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.3% | ₩76,896 | ₩82,525 | ₩89,451 | ₩98,184 | ₩109,544 |
| 6.8% | ₩70,310 | ₩74,818 | ₩80,255 | ₩86,943 | ₩95,378 |
| 7.3% | ₩64,775 | ₩68,445 | ₩72,798 | ₩78,048 | ₩84,507 |
| 7.8% | ₩60,060 | ₩63,088 | ₩66,632 | ₩70,835 | ₩75,903 |
| 8.3% | ₩55,996 | ₩58,524 | ₩61,448 | ₩64,868 | ₩68,926 |
Now (TTM)
- Market cap
- ₩628B
- Enterprise value
- ₩562B
- P/E
- 13.5×
- P/B
- 1.8×
- P/S
- 2.4×
- EV/EBITDA
- —
- Dividend yield
- 1.3%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩32,750 | ₩23,200 | ₩25,350 | ₩20,200 | ₩23,150 |
| Market cap | ₩441B | ₩313B | ₩342B | ₩272B | ₩312B |
| P/E | 14.4× | 9.4× | 9.3× | 8.1× | 9.2× |
| P/B | 1.4× | 1.1× | 1.4× | 1.3× | 1.7× |
| P/S | 1.9× | 1.5× | 2.0× | 1.7× | 2.3× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 1.8% | 1.7% | — | — | — |
Versus similar companies
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: InBody / 인바디 / 041830 / KRX:041830
Source: KRX statistical information